Leaflet: information for the user
Fentanilo Aristo 100 micrograms buccal tablets EFG
Fentanilo Aristo 200 micrograms buccal tablets EFG
Fentanilo Aristo 400 micrograms buccal tablets EFG
Fentanilo Aristo 600 micrograms buccal tablets EFG
Fentanilo Aristo 800 micrograms buccal tablets EFG
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
The active ingredient of Fentanilo Aristo is fentanyl citrate. Fentanyl is a pain relief medication, this medication is known as an opioid used to treat breakthrough pain in adult patients who already receive maintenance treatment with other opioids for their persistent pain (present all the time) associated with cancer.
Breakthrough pain is additional and sudden pain that appears despite already receiving routine analgesic treatment with opioids.
Do not use Fentanilo Aristo:
Warnings and precautions
During treatment with fentanilo, continue to use the opioid analgesic medication you take for your persistent pain (present all the time) associated with cancer.
While under treatment with fentanilo, do not use other fentanilo-based treatments that you may have been prescribed previously for breakthrough pain. If you still have these fentanilo products at home, contact your pharmacist who will instruct you on how to dispose of them.
Keep this medication in a safe and protected place, to which other people cannot access (see section 5, Storage of Fentanilo Aristo for more information).
Inform your doctor or pharmacistBEFOREstarting to use fentanilo:
Consult your doctorDURINGuse of fentanilo:
Long-term use and tolerance
This medication contains fentanilo, an opioid. Repeated use of opioid analgesics may make the medication less effective (your body becomes accustomed to it, known as pharmacological tolerance). You may also become more sensitive to pain when using fentanilo. This is known as hyperalgesia. Increasing the dose of fentanilo may continue to reduce pain for a while, but it may also be harmful. If you notice that the medication is losing its effectiveness, consult your doctor. Your doctor will decide whether it is better to increase the dose or to gradually reduce the use of fentanilo.
Dependence and addiction
Repeated use of fentanilo may also cause dependence, abuse, and addiction, which could lead to a potentially fatal overdose. The risk of these adverse effects may be higher with a higher dose and longer use. Dependence or addiction may cause you to feel a lack of control over the amount of medication you should use or the frequency with which you should use it. You may feel the need to continue using the medication even if it does not help to alleviate pain.
The risk of dependence or addiction varies from person to person. The risk of becoming dependent or addicted to fentanilo may be higher if:
If you notice any of the following symptoms while using fentanilo, it could be a sign of dependence or addiction.
If you notice any of these signs, consult your doctor to determine the best course of treatment for you, when it is appropriate to stop the medication, and how to do it safely.
Seek medical attentionURGENTLY:
What to do if someone takes Fentanilo Aristo accidentally
If you think someone has taken fentanilo accidentally, seek immediate medical attention. Try to keep the person awake until emergency services arrive.
If someone takes fentanilo accidentally, they may experience the same side effects described in the section “If you use more fentanilo than you should.”
Children and adolescents
Do not administer this medication to children and adolescents under 18 years of age.
Other medications and Fentanilo Aristo
Inform your doctor or pharmacist before starting treatment with fentanilo if you are taking, have taken recently, or may need to take any other medication, including the following:
However, if your doctor prescribes fentanilo with sedative medications, the dose and duration of concomitant treatment should be limited by your doctor.
Inform your doctor about all sedative medications you are taking (such as sleep aids, anxiety medications, some allergy medications [antihistamines], or tranquilizers) and follow your doctor's recommended dose strictly. It may be helpful to inform friends or family members to alert them to the symptoms and signs described above. Contact your doctor if you experience these symptoms.
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Use of Fentanilo Aristo with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
Fentanilo should not be used during pregnancy, except after consulting your doctor.
If you use fentanilo for an extended period during pregnancy, there is also a risk that the newborn may experience withdrawal symptoms that can be potentially fatal if not identified and treated by a doctor.
Do not use fentanilo during labor, as fentanilo may cause respiratory depression in the newborn.
Breastfeeding
Fentanilo may pass into the mother's bloodstream and cause adverse effects in the infant. Do not use fentanilo if you are breastfeeding your child. Do not initiate breastfeeding until at least 5 days have passed since the last dose of fentanilo.
Driving and operating machines
Ask your doctor if you can drive or operate machines safely after taking fentanilo. Do not drive or operate machines if: you feel sleepy or dizzy, have blurred vision, see double, or have difficulty concentrating. It is essential to know how you react to fentanilo before driving or operating machines.
Use in athletes
It is reported to athletes that this medication contains a component that may result in a positive analytical result in doping control as positive.
Fentanilo contains sorbitol
This medication contains 67.1 mg of sorbitol in each buccal tablet.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will also explain to you what you can expect from the use of fentanilo, when and for how long you should use it, when you should contact your doctor and when you should discontinue use (see also section 2).
Dosage and frequency
When you start using fentanilo for the first time, your doctor will help you find the dose that will relieve your breakthrough pain. It is very important that you use fentanilo exactly as your doctor tells you. The initial dose is 100 micrograms.
During the determination of the correct dose for you, your doctor may have you take more than one tablet per episode. If your breakthrough pain is not relieved after 30 minutes, use only 1 more tablet of fentanilo during the dose adjustment period.
Once you have determined the correct dose with your doctor, use 1 tablet for a breakthrough pain episode as a general rule. The analgesic dose you need may vary throughout treatment. You may need higher doses. If your breakthrough pain is not relieved after 30 minutes, use only 1 more tablet of fentanilo during this dose adjustment period. Consult your doctor if your correct dose of fentanilo does not relieve your breakthrough pain. Your doctor will decide if it is necessary to modify your dose.
Wait at least 4 hours before treating another breakthrough pain episode with fentanilo.
You must inform your doctor immediately if you need to take fentanilo more than four times a day, as it may be necessary to change your treatment regimen. Your doctor may change the treatment you are receiving to control persistent pain; when persistent pain is controlled, your doctor may need to change your fentanilo dose. If your doctor suspects opioid-related hyperalgesia, they may consider reducing your fentanilo dose (see section 2, "Warnings and precautions"). To achieve more effective relief, inform your doctor of the pain you suffer and how fentanilo is acting in your case, so they can modify your dose as needed.
Do not change the doses of fentanilo or other analgesics on your own. Any change in dosing must be prescribed and monitored by your doctor.
If you are unsure of the correct dose, or if you wish to ask any questions about the use of this medication, contact your doctor.
Administration form
The administration form of fentanilo oral tablets is by oral route. When placing a tablet in the mouth, it dissolves and the medication is absorbed by the buccal mucosa and passes into the blood. This form of taking the medication allows it to be absorbed quickly to relieve your breakthrough pain.
How to use the medication
If you use more Fentanilo Aristo than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to use Fentanilo Aristo
If the breakthrough pain persists, you can take fentanilo according to your doctor's instructions. If the breakthrough pain has disappeared, do not take fentanilo until the next breakthrough pain episode.
If you interrupt treatment with Fentanilo Aristo
You must discontinue fentanilo when you no longer have any breakthrough pain. However, you must continue taking your usual opioid analgesic medication to treat persistent cancer pain, as instructed by your doctor. When you discontinue fentanilo treatment, you may experience withdrawal symptoms similar to possible adverse effects of fentanilo. If you experience withdrawal symptoms or are concerned about pain relief, consult your doctor. Your doctor will evaluate if you need medications to reduce or eliminate withdrawal symptoms.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them. If you notice any of them, inform your doctor.
Severe side effects
Together, these symptoms may be a sign of a potentially fatal condition called adrenal insufficiency, in which the adrenal glands do not produce enough hormones.
Other side effects
Very common:may affect more than 1 in 10 patients
Common:may affect up to 1 in 10 patients
Uncommon:may affect up to 1 in 100 patients
Rare:may affect up to 1 in 1,000 patients
Unknown:the frequency cannot be estimated from available data
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicinal Products for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Conserve this medication in a safe and protected place, where no other people can access it. This medication can cause severe damage and even be fatal to people who use it accidentally, or intentionally when not prescribed.
The strong analgesic fentanilo is a life-threatening risk if taken accidentally by a child. This medication must be kept out of the sight and reach of children.
Medications should not be disposed of through drains or in the trash. Deposit the containers and medications you no longer need at the SIGRE collection point of the pharmacy. Ask your pharmacist how to dispose of the containers and medications you no longer need. In this way, you will help protect the environment.
Composition of Fentanilo Aristo
The active principle is fentanil. Each tablet contains:
The other components are mannitol, sorbitol, citric acid, macrogol, L-arginine, and magnesium stearate.
Appearance of the product and content of the container
The buccal tablets are white, round, and engraved with “1” on one side for fentanil 100 micrograms, with “2” on one side for fentanil 200 micrograms, with “4” on one side for fentanil 400 micrograms, with “6” on one side for fentanil 600 micrograms, and with “8” on one side for fentanil 800 micrograms.
They have an approximate diameter of 10 mm.
Each blister contains 4 buccal tablets, which are presented in boxes of 4 or 28 buccal tablets.
Only some container sizes may be commercially available.
Holder of the marketing authorization
Aristo Pharma GmbH
Wallenroder Straße 8-10
13435 Berlin
Germany
Responsible for manufacturing
Bluepharma – Industria Farmaceutica S.A.
S.Martinho do Bispo, Coimbra,
3045-016, Portugal
or
ARDENA PAMPLONA, S.L. Poligono Mocholi, C/Noain, n°1
Noain, 31110 (Navarra), Spain
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Aristo Pharma Iberia, S.L.
C/ Solana, 26
28850, Torrejón de Ardoz
Madrid. Spain
Last review date of this leaflet:October 2024
The detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
QR Code Fentanilo Aristo 400 micrograms buccal tablets EFG
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.